CompletedNCT02739932
This study exists to understand what helps brain scans or other body measurements work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 12 Years to 25 Years
- Countries
- Canada
- Sponsor
- University of Calgary
- Condition
- Depression
CompletedNCT04618250
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherOver 18 Years
- Countries
- Denmark
- Sponsor
- University of Copenhagen
- Condition
- Schizophrenia
CompletedNCT02845440
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand how people respond to smoking support or smoking-related treatment in practice and what may need to be adjusted.
DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- Depression
CompletedNCT03630822
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Condition
- Schizophrenia
CompletedNCT03156504
This study exists to see whether the medication Ketamine can play a useful role in care. Researchers are trying to understand whether the medication Ketamine can better support energy, concentration, and everyday functioning.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Mayo Clinic
- Condition
- Depression
CompletedNCT03959735
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
DepressionOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Depression
WithdrawnNCT03842345
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.
DepressionOtherOver 18 Years
- Countries
- Global
- Sponsor
- QuantalX Neuroscience
- Condition
- Depression
CompletedNCT03386851
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherOver 19 Years
- Countries
- South Korea
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Condition
- Schizophrenia
CompletedNCT01495741
This study exists to compare options and see whether the medication Asenapine offers something meaningfully different. Researchers are trying to understand what the medication Asenapine could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Bipolarity
CompletedNCT01866098
This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT02037581
This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 12 Years to 29 Years
- Countries
- Germany
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Condition
- Schizophrenia
CompletedNCT03198364
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT02188732
This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Condition
- Schizophrenia
CompletedNCT04068467
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. For people living with Schizophrenia, that matters because support often needs to fit around real routines and access barriers.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Washington
- Condition
- Schizophrenia
CompletedNCT03822416
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Depression
CompletedNCT00666432
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 15 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT01948024
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 80 Years
- Countries
- United States
- Sponsor
- Sun Pharmaceutical Industries Limited
- Condition
- Schizophrenia
CompletedNCT03404882
This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Alberta
- Condition
- Schizophrenia
CompletedNCT03050853
This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Condition
- Schizophrenia
CompletedNCT01053429
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOther
- Countries
- Global
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Schizophrenia
CompletedNCT00454883
This study exists to see whether the medication Ziprasidone can make care clearer and more responsive. Researchers are trying to understand whether the medication Ziprasidone can give earlier or clearer feedback during care.
BipolarityOtherOver 18 Years
- Countries
- Global
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Bipolarity
CompletedNCT00650611
This study exists to better understand the safety of this type of care and how manageable it feels in practice. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Schizophrenia
CompletedNCT02756065
This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 30 Years
- Countries
- United States
- Sponsor
- Washington University Early Recognition Center
- Condition
- Schizophrenia
CompletedNCT00825539
This study exists to better understand the safety of the medication AQW051 and how manageable it feels in practice. Researchers are trying to understand whether the medication AQW051 can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Novartis Pharmaceuticals
- Condition
- Schizophrenia
CompletedNCT03062267
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 99 Years
- Countries
- United States
- Sponsor
- University of Washington
- Condition
- Schizophrenia